Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032
Year: 2011
Type: article
Study design: Clinical Trial
Source: Urology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1188137174, G1257575315, G1545560008, G1790576020, G2003196729, G2009210887, G2043432835, G2160369479, G2201816905, G2237949143, G2276667821, G2320693132, G2345882982, G2435896781, G2485941414, G2562936776, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3204966229, G3239274266, G3337849518, G3484997517, City of Hope Southwest Oncology Group Clinical Trials, G36541222, G3792990546, G379387698, G3939550896, G398851121, G4053304217, G413878341, G4152208120, G425646771, G4292856267, Southwest Oncology Group, G4719029039, G4935167430, LSUHSC-Shreveport Feist Weiller Cancer Center MBCCOP, G5034745817, G5519497345, G5566132837, G5761683024, G5805678965, G6211207823, G6290519354, G6723594983, SOUTHWEST ONCOLOGY GROUP, G691096829, G7061256793, G7696306938, G8523218764, G860872252, G8777682367, G8898045420, PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP, G924713883
OpenAlex ID: W2090685497
